Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
INOVIO PHARMACEUTICALS, INC. (INO)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 |
|
Returns on Capital |
ROIC (excluding intangibles) | -98.3% | -101.1% | -74.3% | -164.6% | -112.7% | -82.1% | -74.7% | -37.8% |
ROIC (including intangibles) | -128.9% | -83.1% | -46.2% | -122.0% | -131.3% | -65.5% | -69.3% | -26.3% |
ROE | -120.3% | -75.4% | -26.0% | -2051.3% | -110.6% | -59.4% | -62.7% | -19.1% |
ROA | -76.8% | -60.7% | -22.2% | -77.0% | -73.4% | -45.2% | -44.5% | -15.7% |
|
Cash Conversion Cycle |
Days sales outstanding | 417.5 | 1,124.3 | 914.1 | 180.4 | 39.7 | 51.9 | 163.3 | 65.7 |
Cash conversion cycle | | | | | | | | |
|